Monashee Investment Management LLC Kura Oncology, Inc. Transaction History

Monashee Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$9.62 - $13.99 $1.15 Million - $1.68 Million	120,000 New	120,000 $1.27 Million
Q1 2021 May 14, 2021	SELL	$24.75 - $39.14 $2.85 Million - $4.5 Million	-115,000 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$29.0 - $41.62 $3.34 Million - $4.79 Million	115,000 New	115,000 $3.76 Million
Q3 2019 Nov 12, 2019	SELL	$14.75 - $20.87 $3.48 Million - $4.92 Million	-235,956 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$14.71 - $19.79 $3.47 Million - $4.67 Million	235,956 New	235,956 $4.65 Million
Q3 2018 Nov 13, 2018	SELL	$16.65 - $21.85 $2.91 Million - $3.82 Million	-175,000 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$14.8 - $18.8 $2.59 Million - $3.29 Million	175,000 New	175,000 $3.19 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.